BCAP31

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA003906

Antibody CAB015350

Antibody CAB015424

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignancies showed moderate to strong cytoplasmic positivity. Basal cell carcinomas were weaker stained.Most of the malignant cells displayed moderate cytoplasmic positivity. Colorectal and breast cancers showed strong staining which also was observed in a few cases of liver and urothelial cancers. Malignant lymphomas were negative while skin cancers generally displayed weak immunoreactivity.Most malignant tissues showed moderate cytoplasmic positivity. Strong cytoplasmic staining was observed in a majority of colorectal and urothelial cancers but also in several cases of breast, liver and pancreatic cancers. Malignant lymphomas were mainly negative.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected